the present study was undertaken to define an interpretative guideline for disk diffusion susceptibility testing with fosfomycin trometamol , a new antimicrobial agent which has been developed for the treatment of urinary tract infections .
C0016610
fosfomycin
C0042029
of urinary tract infections